首都医科大学学报 ›› 2026, Vol. 47 ›› Issue (4): 792-798.doi: 10.3969/j.issn.1006-7795.2026.04.020

• 临床研究 • 上一篇    下一篇

基于高通量光纤拉曼探头的拉曼光谱实时诊断技术在膀胱肿瘤在体无创诊断中的应用

李家兴1,王晓桐1,田忠秋2,黄山3,顾海涵1,尹航1*   

  1. 1.首都医科大学附属北京朝阳医院泌尿外科,北京 100020; 2.首都医科大学附属北京朝阳医院病理科,北京 100020; 3.青岛大学附属医院泌尿外科,山东 青岛 266003
  • 收稿日期:2025-12-16 修回日期:2026-03-05 出版日期:2026-08-21 发布日期:2026-07-26
  • 通讯作者: 尹航 E-mail:dr.yinhang@gmail.com
  • 基金资助:
    北京市医院管理中心临床医学发展专项经费资助项目(YGLX202306)。

Application of real-time Raman spectroscopy based on a high-throughput optical fiber probe for the in vivo and non-invasive diagnosis of bladder tumors

Li Jiaxing1, Wang Xiaotong1, Tian Zhongqiu2, Huang Shan3, Gu Haihan1, Yin Hang1   

  1. 1.Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020 , China; 2.Department of Pathology, Beijing Chaoyang Hospital, Capital Medical University, Beijing  100020, China; 3. Department of Urology, Qingdao University Affiliated Hospital, Qingdao 266003, Shandong Province, China
  • Received:2025-12-16 Revised:2026-03-05 Online:2026-08-21 Published:2026-07-26
  • Supported by:
    This study was supported by Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support(YGLX202306).

摘要: 目的  使用高通量光纤拉曼探头,在体采集膀胱肿瘤组织与正常黏膜的拉曼光谱数据,并基于主成分分析神经网络(principal component analysis neural network,PCANet)构建诊断模型并评估其效能,探索其在膀胱肿瘤无创实时诊断中的应用。方法  对接受膀胱镜检查并行随机活检或经尿道膀胱肿瘤电切术的患者,采用高通量光纤拉曼探头于术中对可疑肿瘤组织与正常黏膜组织进行拉曼光谱采集并获取相应位置的组织样本。所有采样位点均经术后病理学检查确认,并据此将拉曼光谱数据划分为肿瘤组与正常黏膜组,采用PCANet构建膀胱肿瘤拉曼诊断模型。结果  本研究共纳入150例患者,其中有134例经术后病理诊断为膀胱肿瘤。共在体采集196个肿瘤组织位点与329个正常黏膜位点的拉曼光谱数据,并发现肿瘤组织与正常黏膜组织在916、1 094、1 290、1 346、1 436、1 672 cm-1共6个特征峰存在显著差异。基于PCANet的诊断模型对在体膀胱拉曼光谱数据进行分类的诊断灵敏度为90.6%,特异性为91.3%。结论  基于高通量光纤拉曼探头的拉曼光谱实时诊断技术能够实现膀胱肿瘤的快速、无创在体诊断,诊断效能优异,具备显著的临床转化前景。

关键词: 拉曼光谱, 无创诊断, 膀胱肿瘤, 神经网络, 膀胱镜检查, 光纤技术

Abstract: Objective  To collect Raman spectral data of bladder tumor tissues and normal mucosa in vivo by using a high-throughput fiber-optic Raman probe, construct a diagnostic model based on Principal Component Analysis Neural Network (PCANet), evaluate its performance, and explore its application in non-invasive real-time diagnosis of bladder tumors.Methods  During cystoscopy, patients undergoing random biopsy or transurethral resection of bladder tumors were included. In vivo Raman spectra were collected from suspicious tumor tissues and normal mucosa by using a high-throughput fiber-optic Raman probe, and tissue samples from corresponding sites were obtained. All sampling sites were confirmed by postoperative pathological examination. Based on pathological results, Raman spectral data were categorized into tumor and normal mucosa groups, and a PCANet-based diagnostic model for bladder tumors was constructed.Results  A total of 150 patients were enrolled, among whom 134 were pathologically diagnosed with bladder tumors postoperatively. In vivo Raman spectra were collected from 196 tumor tissue sites and 329 normal mucosa sites. Significant differences were observed at six characteristic peaks: 916, 1 094, 1 290, 1 346, 1 436, 1 672 cm-1. The PCANet-based diagnostic model demonstrated a sensitivity of 90.6% and a specificity of 91.3% in classifying in vivo bladder Raman spectra.Conclusion  This study demonstrates that the real-time Raman spectroscopy diagnosis technology based on high-throughput fiber Raman probes can achieve rapid and non-invasive in vivo diagnosis of bladder tumors, with excellent diagnostic performance and significant clinical application prospects.

Key words: Raman spectroscopy, non-invasive diagnosis, bladder tumor, neural networks, cystoscopy, fiber optic technology

中图分类号: